Quarterly report pursuant to Section 13 or 15(d)

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)

v3.22.2.2
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Aug. 06, 2021
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Securities Financing Transaction [Line Items]          
Capital contribute       $ 5,000,000 $ 0
Advertising expense   $ 0 $ 2,751 3,402 5,725
Research and development expenses   $ 272,144 $ 268,917 $ 798,913 $ 876,778
Warrants Outstanding [Member]          
Securities Financing Transaction [Line Items]          
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount   105,380,666 250,000    
Options Outstanding [Member]          
Securities Financing Transaction [Line Items]          
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount   2,626,847 3,349,793    
VDA Purchase Agreement [Member]          
Securities Financing Transaction [Line Items]          
Capital contribute $ 5,000,000        
Share acquisition 162,900,947        
Warrants issued 105,380,666